Cephalexin and Carbatrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cephalexin (cephalexin) and Carbatrol (carbamazepine). Common drug interactions include sinus tachycardia among females and gastrointestinal disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Cephalexin and Carbatrol. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 30,580 Cephalexin users. Check the latest studies of Cephalexin.

What is Carbatrol?

Carbatrol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 1,979 Carbatrol users. Check the latest studies of Carbatrol.



On Jul, 13, 2026

11 people who take Cephalexin and Carbatrol together, and have interactions are studied.

Cephalexin and Carbatrol drug interactions.

What are the common drug interactions of Cephalexin and Carbatrol, by gender? *:

female:

  1. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  2. Cardiac failure congestive
  3. Death
  4. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  5. Bradycardia (abnormally slow heart action)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Dehydration (dryness resulting from the removal of water)
  8. Diarrhoea
  9. Drug ineffective
  10. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

male:

  1. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  2. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  5. Syncope (loss of consciousness with an inability to maintain postural tone)
  6. Blood pressure increased
  7. Chronic kidney disease
  8. Eye pain
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Photopsia (presence of perceived flashes of light)

What are the common drug interactions of Cephalexin and Carbatrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  2. Electrocardiogram qt prolonged

30-39:

n/a

40-49:

  1. Renal failure (kidney dysfunction)
  2. Renal tubular necrosis (death of kidney tubules)
  3. Chronic kidney disease
  4. Nephrogenic anaemia (anaemia due to kidney disease)

50-59:

  1. Heart rate decreased
  2. Influenza
  3. Malaise (a feeling of general discomfort or uneasiness)

60+:

  1. Cardiac failure congestive
  2. Death
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Bradycardia (abnormally slow heart action)
  5. Pneumonia

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 36.36%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 36.36%
  3. Complex Partial Seizures (epileptic seizure): 3 people, 27.27%
  4. Diabetes: 2 people, 18.18%
  5. Headache (pain in head): 1 person, 9.09%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cephalexin and Carbatrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cephalexin and Carbatrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cephalexin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Carbatrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cephalexin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carbatrol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cephalexin and carbamazepine (the active ingredients of Cephalexin and Carbatrol, respectively), and Cephalexin and Carbatrol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: